[1] R.D. Blakely, H.E. Berson, R.T. Fremeau Jr., M.G. Caron, M.M. Peek, H.K. Prince,
C.C. Bradley, Cloning and expression of a functional serotonin transporter
from rat brain, Nature 354 (1991) 66e70, https://doi.org/10.1038/354066a0.
[2] M.J. Kuhar, R.H. Roth, G.K. Aghajanian, Synaptosomes from forebrains of rats
with midbrain raphe lesions: selective reduction of serotonin uptake,
J. Pharmacol. Exp. Therapeut. 181 (1972) 36e45.
[3] B. Olivier, W. Soudijn, I. van Wijngaarden, Serotonin, dopamine and norepinephrine transporters in the central nervous system and their inhibitors, Prog.
Drug Res. 54 (2000) 59e119.
[4] N. Ozaki, D. Goldman, W.H. Kaye, K. Plotnicov, B.D. Greenberg, J. Lappalainen,
G. Rudnick, D.L. Murphy, Serotonin transporter missense mutation associated
with a complex neuropsychiatric phenotype, Mol. Psychiatr. 8 (2003)
933e936.
[5] J.S. Sutcliffe, R.J. Delahanty, H.C. Prasad, J.L. McCauley, Q. Han, L. Jiang, C. Li,
S.E. Folstein, R.D. Blakely, Allelic heterogeneity at the serotonin transporter
locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors, Am. J. Hum. Genet. 77 (2005) 265e279.
[6] D.J. Samuvel, L.D. Jayanthi, N.R. Bhat, S. Ramamoorthy, A role for p38 mitogenactivated protein kinase in the regulation of the serotonin transporter: evidence for distinct cellular mechanisms involved in transporter surface
expression, J. Neurosci. 25 (2005) 29e41, https://doi.org/10.1523/JNEUROSCI.3754-04.2005.
[7] C.B. Zhu, W.A. Hewlett, I. Feoktistov, I. Biaggioni, R.D. Blakely, Adenosine receptor, protein kinase G, and p38 mitogen-activated protein kinasedependent up-regulation of serotonin transporters involves both transporter
Declaration of competing interest
The authors have no conflicts of interest regarding this study.
Acknowledgement
This work was supported by JSPS KAKENHI Grant Numbers
19H03409, 16H05133, 16K15318 and 25293061. This work was also
supported by grants from the Takeda Science Foundation, the
Uehara Memorial Foundation and the Smoking Research Foundation. This work was performed using equipment at the Radiation
K. Taguchi, M. Kaneko, S. Motoike et al.
[8]
[9]
[10]
[11]
[12]
[13]
[14]
[15]
[16]
Biochemical and Biophysical Research Communications xxx (xxxx) xxx
trafficking and activation, Mol. Pharmacol. 65 (2004) 1462e1474, https://
doi.org/10.1124/mol.65.6.1462.
H. Yoshida, ER stress and diseases, FEBS J. 274 (2007) 630e658, https://
doi.org/10.1111/j.1742-4658.2007.05639.x.
D. Ron, P. Walter, Signal integration in the endoplasmic reticulum unfolded
protein response, Nat. Rev. Mol. Cell Biol. 8 (2007) 519e529, https://doi.org/
10.1038/nrm2199.
M. Schroder, R.J. Kaufman, The mammalian unfolded protein response, Annu.
Rev.
Biochem.
74
(2005)
739e789,
https://doi.org/10.1146/
annurev.biochem.73.011303.074134.
J.S. Bonifacino, A.M. Weissman, Ubiquitin and the control of protein fate in the
secretory and endocytic pathways, Annu. Rev. Cell Dev. Biol. 14 (1998) 19e57,
https://doi.org/10.1146/annurev.cellbio.14.1.19.
C. Hirsch, R. Gauss, S.C. Horn, O. Neuber, T. Sommer, The ubiquitylation machinery of the endoplasmic reticulum, Nature 458 (2009) 453e460, https://
doi.org/10.1038/nature07962.
M. Nobukuni, H. Mochizuki, S. Okada, N. Kameyama, A. Tanaka, H. Yamamoto,
T. Amano, T. Seki, N. Sakai, The C-terminal region of serotonin transporter is
important for its trafficking and glycosylation, J. Pharmacol. Sci. 111 (2009)
392e404.
M. Fujiwara, H. Yamamoto, T. Miyagi, T. Seki, S. Tanaka, I. Hide, N. Sakai, Effects of the chemical chaperone 4-phenylbutylate on the function of the serotonin transporter (SERT) expressed in COS-7 cells, J. Pharmacol. Sci. 122
(2013) 71e83, https://doi.org/10.1254/jphs.12194FP.
K. Katarao, S. Murakawa, M. Asano, N. Usuki, H. Yamamoto, T. Shirafuji,
S. Tanaka, I. Hide, N. Sakai, The development of screening methods to identify
drugs to limit ER stress using wild-type and mutant serotonin transporter,
Acta Histochem. Cytoc. 49 (2016) 197e206, https://doi.org/10.1267/
ahc.16029.
M. Kaneko, M. Ishiguro, Y. Niinuma, M. Uesugi, Y. Nomura, Human HRD1
[17]
[18]
[19]
[20]
[21]
[22]
[23]
protects against ER stress-induced apoptosis through ER-associated degradation, FEBS Lett. 532 (2002) 147e152, https://doi.org/10.1016/s00145793(02)03660-8.
M. Kaneko, Y. Nomura, ER signaling in unfolded protein response, Life Sci. 74
(2003) 199e205, https://doi.org/10.1016/j.lfs.2003.09.007.
T. Omura, M. Kaneko, N. Tabei, Y. Okuma, Y. Nomura, Immunohistochemical
localization of a ubiquitin ligase HRD1 in murine brain, J. Neurosci. Res. 86
(2008) 1577e1587, https://doi.org/10.1002/jnr.21616.
M. Kaneko, H. Koike, R. Saito, Y. Kitamura, Y. Okuma, Y. Nomura, Loss of
HRD1-mediated protein degradation causes amyloid precursor protein accumulation and amyloid-beta generation, J. Neurosci. 30 (2010) 3924e3932,
https://doi.org/10.1523/JNEUROSCI.2422-09.2010.
H. Yang, X. Zhong, P. Ballar, S. Luo, Y. Shen, D.C. Rubinsztein, M.J. Monteiro,
S. Fang, Ubiquitin ligase Hrd1 enhances the degradation and suppresses the
toxicity of polyglutamine-expanded huntingtin, Exp. Cell Res. 313 (2007)
538e550, https://doi.org/10.1016/j.yexcr.2006.10.031.
M. Asano, S. Motoike, C. Yokota, N. Usuki, H. Yamamoto, T. Urabe, K. Katarao,
I. Hide, S. Tanaka, M. Kawamoto, M. Irifune, N. Sakai, SKF-10047, a prototype
Sigma-1 receptor agonist, augmented the membrane trafficking and uptake
activity of the serotonin transporter and its C-terminus-deleted mutant via a
Sigma-1 receptor-independent mechanism, J. Pharmacol. Sci. 139 (2019)
29e36, https://doi.org/10.1016/j.jphs.2018.11.005.
T. Omura, M. Kaneko, M. Onoguchi, S. Koizumi, M. Itami, M. Ueyama,
Y. Okuma, Y. Nomura, Novel functions of ubiquitin ligase HRD1 with transmembrane and proline-rich domains, J. Pharmacol. Sci. 106 (2008) 512e519,
https://doi.org/10.1254/jphs.08005fp.
N. Sakai, N. Kodama, S. Ohmori, K. Sasaki, N. Saito, Involvement of the actin
cytoskeleton in the regulation of serotonin transporter (SET) activity: possible
mechanism underlying SET regulation by protein kinase C, Neurochem. Int. 36
(2000) 567e579. S0197-0186(99)00160-6 [pii].
...
論文の公開元へ
